Media & Announcements
Polpharma Group at CPHI Milan 2026: Strengthening Partnerships Across the Global Pharmaceutical Value Chain
At CPHI Milan 2026, a Polpharma delegation led by CEO Sebastian Szymanek met partners on APIs, finished dosage forms, CDMO services and new technologies.
Group News
October 21, 2026
Polpharma at EFNI 2026: Building Innovation, Resilience and Europe’s Future
At EFNI 2026 in Sopot, Polpharma shared its innovation experience and joined debates on resilient supply chains and Europe’s industrial future.
Group News
October 21, 2026
Polpharma strengthens it's position in CEE - Biofarm, the leader of the Romanian market, joins the Group.
Polpharma Group has completed the acquisition of the Romanian pharmaceutical company Biofarm. The transaction is a clear step in the execution of the Group’s growth strategy and strengthens its position in Central and Eastern Europe.
Group News
July 27, 2026
Polpharma Group’s R&D supports growth in key therapeutic areas.
Polpharma Group's research and development capabilities support growth across its key therapeutic areas and strengthen its product pipeline.
Group News
June 26, 2026
Polpharma strengthens it's position in CEE - Biofarm, the leader of the Romanian market, joins the Group.
Polpharma Group has completed the acquisition of the Romanian pharmaceutical company Biofarm. The transaction is a clear step in the execution of the Group’s growth strategy and strengthens its position in Central and Eastern Europe.
Group News
July 27, 2026
.avif)
.avif)
The Leonardo Innovation Program won the Gold Stevie Awards® gold statuette in the 19th edition of the prestigious international competition International Business Awards®!
The Leonardo employee innovation programme wins Gold at the Stevie International Business Awards for creativity, engagement and innovative communication.
Group News
August 16, 2022
Polpharma API completed step 1. Risk Evaluation according to EMA’s request concerning presence of nitrosamines in drug products.
Polpharma completed EMA risk assessment for nitrosamines in chemically synthesised APIs, identifying optimisation parameters for highest quality.
Group News
December 17, 2020
Press releases
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Corporate Social Responsibility
ZF Polpharma
June 11, 2021
Polpharma awarded with Golden and Diamond CSR Leaves
Polityka weekly awards Polpharma the special Diamond CSR Leaf and a Golden CSR Leaf, honouring ten years of leadership in responsible, sustainable business.
Group News
Polpharma Group
ZF Polpharma
April 1, 2021
Merger of companies
Polpharma Biuro Handlowe and Medana Pharma merge with parent Zakłady Farmaceutyczne POLPHARMA S.A., which assumes all their rights, contracts and obligations.
Careers
ZF Polpharma
March 30, 2021
POLPHARMA AWARDED IN THE COMPETITION FAMILY AND HUMAN FRIENDLY COMPANY
Polpharma is distinguished in the Humanites Institute's Family and Human Friendly Company competition for supporting staff on maternity and paternity leave.
Careers
ZF Polpharma
March 30, 2021
Polpharma ranked #1 in the Pharmaceuticals and Biotechnology category in the Forbes Poland’s Best Employers 2021 ranking!
Polpharma takes first place in the Pharmaceuticals and Biotechnology category of Forbes Poland's Best Employers 2021, based on an anonymous industry survey.
Latest stories
featured
.avif)
For the media
Media Kit
Logos, photography and the Group boilerplate.
ZIP file (112.28 kb) updated quarterly
Group factsheet
Revenue, footprint, pipeline, employment and history.
Pdf file (112.28 kb) updated quarterly
Press Contact
Logos, photography and the Group boilerplate.
press@polpharma.com
RESPONDS WITHIN ONE BUSINESS DAY